Goodpasture Syndrome: Understanding Anti-GBM Disease
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026
Quick Answer
Goodpasture syndrome is a rare autoimmune disorder, also known as anti-glomerular basement membrane (anti-GBM) disease, where the body produces antibodies that attack the connective tissue (collagen) in the lungs and kidneys. This causes inflammation and damage, often leading to coughing up blood and kidney dysfunction. It requires urgent medical intervention but has a high success rate with early treatment.
What the research says
Combining plasma exchange with immune-suppressing drugs improved survival and kidney outcomes. In a retrospective study of 221 consecutive patients, patient and kidney survival at 1 year were 72.7% and 25.0%; plasmapheresis plus corticosteroids and cyclophosphamide was linked to a lower risk of death (hazard ratio 0.31) and of kidney failure (hazard ratio 0.60), while corticosteroids plus cyclophosphamide without plasmapheresis did not improve kidney outcomes (p = 0.73) (Cui et al., Medicine, 2011).
Five-year survival is high in modern cohorts, but kidney outcomes remain the weak point. In a French nationwide cohort of 119 patients, 5-year overall survival was 92%, plasmapheresis was associated with better survival (hazard ratio 0.29, 95% CI 0.08–0.98), and 46% of patients had end-stage kidney disease at 3 months (Marques et al., Frontiers in Immunology, 2019).
Outcomes have improved sharply over three decades. In a Chinese cohort of 448 patients, 1-year mortality fell from 57.1% (1991–2000) to 6.9% (2011–2020); serum creatinine and the percentage of crescents at diagnosis predicted kidney failure, and plasma exchange was associated with better patient survival (hazard ratio 0.40, 95% CI 0.16–0.95) (Jia et al., American Journal of Nephrology, 2022).
Figure 1: Goodpasture syndrome involves an autoimmune attack on the vital collagen structures within the lungs and kidneys.
Key Takeaways
Feature | Description |
Condition Type | Rare autoimmune pulmonary-renal syndrome |
Primary Targets | Lungs (air sacs) and Kidneys (filtering units) |
Key Symptom | Coughing up blood and blood in urine |
Primary Cause | Anti-GBM antibodies attacking Type IV collagen |
Urgency | Medical emergency requiring immediate care |
Main Treatment | Plasmapheresis, steroids, and immunosuppressants |
Understanding the Autoimmune Attack
Goodpasture syndrome is a rare condition that disrupts the body's natural defense system. In a healthy body, the immune system protects against invaders like bacteria and viruses. However, in those with this syndrome, the body produces specialized proteins called anti-glomerular basement membrane (anti-GBM) antibodies. These antibodies mistakenly target Type IV collagen, a structural protein found in the basement membranes of the kidneys' filtering units (glomeruli) and the lungs' air sacs (alveoli) [1].
When these antibodies attach to the collagen, they trigger intense inflammation. In the kidneys, this leads to a condition called glomerulonephritis, which can rapidly progress to kidney failure. In the lungs, the damage causes the small blood vessels to leak, leading to pulmonary hemorrhage—a life-threatening situation where bleeding occurs within the lung tissue [1] [2].
Symptoms and Early Warning Signs
Symptoms of Goodpasture syndrome often appear in two distinct phases, usually starting with the lungs before progressing to the kidneys. Recognizing these signs early is critical for a positive outcome.
Lung-Related Symptoms | Kidney-Related Symptoms |
Shortness of breath (dyspnea) | Blood in urine (hematuria) |
Persistent cough | Foamy or tea-colored urine |
Coughing up blood (hemoptysis) | Decreased urine output |
Chest pain | High blood pressure (hypertension) |
Fatigue and weakness | Swelling in legs or feet (edema) |
Pale skin (pallor) | Nausea and vomiting |
Figure 2: Common symptoms of Goodpasture syndrome across pulmonary and renal systems.
Causes and Risk Factors
While the exact reason the immune system begins this attack remains unknown, researchers believe a combination of genetic predisposition and environmental triggers plays a role. The condition is most commonly associated with the HLA-DR15 genetic marker [1].
Environmental triggers that may activate the disease include:
Smoking: Cigarette smoke is a major risk factor, particularly for lung involvement.
Infections: Recent viral infections like the cold or flu.
Chemical Exposure: Breathing in hydrocarbon chemicals (such as propane or methane) or metallic dust.
Drug Use: Snorting cocaine has been linked to increased risk.
The disease tends to affect two specific age groups: young adults in their teens to 30s and older adults in their 60s to 70s [1] [2]. Overall, it is more common in men [5].
The Diagnostic Process
Because Goodpasture syndrome is a medical emergency, healthcare providers move quickly to confirm the diagnosis using a combination of tests.
Blood Tests: Checking for the presence of anti-GBM antibodies and measuring kidney function (eGFR).
Urinalysis: Looking for blood and high levels of protein (proteinuria).
Imaging: Chest X-rays or CT scans to identify lung bleeding or damage.
Kidney Biopsy: Removing a tiny tissue sample to look for the characteristic antibody patterns under a microscope [1].
Management and Treatment Strategies
The goal of treatment is threefold: remove the harmful antibodies from the blood, stop the body from producing new ones, and manage the resulting organ damage.
Treatment Type | Purpose |
Plasmapheresis | A process that filters the blood to remove existing anti-GBM antibodies. |
Corticosteroids | High-dose medications (like prednisone) to reduce immediate inflammation. |
Immunosuppressants | Drugs (like cyclophosphamide) to stop the immune system from making new antibodies. |
Supportive Care | Dialysis for kidney failure or oxygen therapy for lung distress. |
Figure 3: The standard care journey for managing Goodpasture syndrome, from medication to antibody filtration.
Outlook and Long-Term Recovery
With modern treatment, the outlook for Goodpasture syndrome has improved significantly. Most patients respond well if care begins before severe kidney damage occurs. Unlike many other autoimmune diseases, the body typically only produces these specific antibodies for a limited time—ranging from a few weeks to two years. Once the antibodies disappear, relapses are extremely rare [1] [2].
Conclusion
Goodpasture syndrome is a formidable condition, but it is one that modern medicine is well-equipped to handle. By understanding the triggers and recognizing the early signs of lung and kidney distress, individuals can seek the life-saving care they need. Protecting your health means staying vigilant and working closely with specialists to ensure a full recovery.
Related Reading
Frequently Asked Questions
What is the main cause of Goodpasture syndrome?
The exact cause is unknown, but it involves the immune system mistakenly producing antibodies that attack collagen in the lungs and kidneys.
Is Goodpasture syndrome a type of cancer?
No, it is an autoimmune disease, not cancer.
How rare is this condition?
Goodpasture syndrome is extremely rare, affecting fewer than two people per million annually.
Can you die from Goodpasture syndrome?
Yes, it is life-threatening if untreated, primarily due to lung bleeding or kidney failure.
What is the primary treatment?
The primary treatments are plasmapheresis (blood filtering), corticosteroids, and immunosuppressants.
Does it affect men or women more?
Goodpasture syndrome affects both, but lung involvement is more common in young men, while older adults are affected equally.
Is it contagious?
No, it is not a contagious disease.
Can children get Goodpasture syndrome?
Goodpasture syndrome is rare in children but can occur; it is most common in young adults and seniors.
What is anti-GBM disease?
Anti-GBM disease is another name for Goodpasture syndrome, referring to the anti-glomerular basement membrane antibodies.
How do doctors test for it?
Tests include blood work for antibodies, urinalysis, chest imaging, and kidney biopsies.
What is plasmapheresis?
Plasmapheresis is a procedure where your blood is removed, filtered to take out harmful antibodies, and then returned to your body.
How long does treatment last?
Intensive treatment usually lasts several weeks, followed by maintenance medications for several months.
Can my kidneys recover?
If caught early, kidneys can recover. If damage is severe, dialysis or a transplant may be needed.
What are the first signs?
Lung symptoms like shortness of breath and coughing up blood are often the first signs.
Does smoking affect the disease?
Yes, smoking significantly increases the risk of severe lung bleeding.
Is there a genetic link?
Yes, the HLA-DR15 gene is often associated with the condition.
Can environmental chemicals trigger it?
Exposure to hydrocarbons (like propane) and metallic dust has been linked to the disease.
What is the survival rate?
With modern treatment, the one-year survival rate is over 90%.
Can the disease come back?
Relapses are very rare once the antibodies have cleared.
Is Goodpasture syndrome painful?
Goodpasture syndrome can cause chest pain and general discomfort, but it is primarily characterized by organ dysfunction.
What is the difference between Goodpasture and vasculitis?
Goodpasture is a specific anti-GBM disease, while vasculitis is a broader category of blood vessel inflammation.
What kind of doctor treats this?
Nephrologists (kidney specialists) and pulmonologists (lung specialists) typically lead the care team.
Are there any specific diets to follow?
If kidney function is affected, a renal-friendly diet low in salt and potassium may be recommended.
Can I exercise with Goodpasture syndrome?
During active treatment, rest is vital. Recovery involves a gradual return to activity as directed by your doctor.
What is Type IV collagen?
Type IV collagen is a specific protein that provides structure to the basement membranes in the lungs and kidneys.
How does a kidney biopsy work?
A doctor uses a thin needle to take a tiny sample of kidney tissue for examination.
What are the side effects of corticosteroids?
Common side effects include weight gain, mood changes, and increased risk of infection.
Can I get a kidney transplant?
Yes, if the kidneys fail, a transplant is an option once the antibodies are gone.
What is hemoptysis?
Hemoptysis is the medical term for coughing up blood.
What is hematuria?
Hematuria is the medical term for blood in the urine.
Does the disease affect the heart?
Not directly, but severe lung or kidney issues can put stress on the heart.
Can stress trigger a relapse?
While relapses are rare, managing stress is recommended for overall immune health.
How long do the antibodies stay in the blood?
The antibodies usually clear within weeks to two years.
Is there a cure?
While "remission" is the standard term, most people do not experience the disease again after successful treatment.
What happens if I don't get treatment?
Untreated Goodpasture syndrome leads to rapid kidney failure and life-threatening lung bleeding.
Can flu shots trigger it?
There is no evidence that vaccines trigger Goodpasture syndrome.
Is it related to lupus?
Both are autoimmune diseases, but they involve different types of antibody attacks.
What is the GBM?
The glomerular basement membrane is the part of the kidney that filters waste from the blood.
How common are nosebleeds in this condition?
Nosebleeds can occur as part of the respiratory symptoms.
Does it affect the skin?
While collagen is in the skin, Goodpasture syndrome specifically targets lung and kidney collagen.
Can pregnancy affect the disease?
Autoimmune conditions require careful management during pregnancy; consult a specialist.
What is proteinuria?
Proteinuria is the presence of excess protein in the urine, a sign of kidney damage.
Is it more common in certain ethnicities?
Goodpasture syndrome can affect people of all backgrounds.
What is cyclophosphamide?
Cyclophosphamide is a powerful immunosuppressant used to stop antibody production.
Can I live a normal life after recovery?
Yes, most people return to their normal activities after successful treatment.
How often do I need follow-up appointments?
Initially frequent, then decreasing to annual checkups once stable.
What is an eGFR test?
An eGFR test measures how well your kidneys are filtering your blood.
Can Goodpasture syndrome be prevented?
Avoiding smoking and chemical exposure may reduce the risk of triggers.
What is a bronchoscopy?
A procedure where a camera is used to look inside the lungs.
Why is it called Goodpasture syndrome?
Goodpasture syndrome is named after Ernest Goodpasture, who first described the condition in 1919.
This article is for informational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare provider for any questions regarding a medical condition.
References
Cleveland Clinic. Goodpasture Syndrome (Anti-GBM Disease). Cleveland Clinic. Last updated June 4, 2024. https://my.clevelandclinic.org/health/diseases/5927-goodpasture-syndrome
Rout P, DeVrieze BW. Goodpasture Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated June 1, 2024. PMID: 29083697. https://www.ncbi.nlm.nih.gov/books/NBK459291/
National Organization for Rare Disorders (NORD). Goodpasture Syndrome. NORD Rare Disease Database. Accessed October 15, 2026. https://rarediseases.org/mondo-disease/anti-glomerular-basement-membrane-disease
Mayo Clinic Staff. Glomerulonephritis - Symptoms and causes. Mayo Clinic. Accessed October 15, 2026. https://www.mayoclinic.org/diseases-conditions/glomerulonephritis/symptoms-causes/syc-20355705
Johns Hopkins Medicine. Goodpasture Syndrome. Johns Hopkins Medicine. Published July 2, 2024. https://www.hopkinsmedicine.org/health/conditions-and-diseases/goodpasture-syndrome
Cui Z, Zhao J, Jia XY, et al. Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore). 2011;90(5):303-311. PMID 21862934. https://doi.org/10.1097/MD.0b013e31822f6f68
Marques C, Carvelli J, Biard L, et al. Prognostic factors in anti-glomerular basement membrane disease: a multicenter study of 119 patients. Frontiers in Immunology. 2019;10:1665. PMID 31396214. https://doi.org/10.3389/fimmu.2019.01665
Jia XY, Xu HY, Jia XY, et al. Predictors of kidney outcomes of anti-glomerular basement membrane disease in a large Chinese cohort. American Journal of Nephrology. 2022;53(5):397-406. PMID 35462364. https://doi.org/10.1159/000523713
Medical disclaimer
The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Comments